Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

被引:104
|
作者
Steinauer, KK [1 ]
Gibbs, I [1 ]
Ning, SC [1 ]
French, JN [1 ]
Armstrong, J [1 ]
Knox, SJ [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 48卷 / 02期
关键词
cyclooxygenase-2; radiation; prostate cancer; prostaglandin E-2; NS-398;
D O I
10.1016/S0360-3016(00)00671-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the impact of gamma-irradiation on cyclooxygenase-2 (COX-2) expression and its enzymatic activity in PC-3 cells. Cell cycle redistribution, viability, and apoptosis were quantitated in control and irradiated cells with or without the COX-2 inhibitor NS-398. Methods and Materials: Western blot analysis was used to assess COX-2 protein expression, Prostaglandin (PGE,) was measured after addition of arachidonic acid (AA) using a Monoclonal Immunoassay Kit. Cell cycle and apoptosis were assessed using flow cytometry. Results: We observed a dose-dependent increase in COX-2 of 37.0%, 79.7%, and 97.5% following irradiation with 5,10, and 15 Gy, respectively. The PGE(2) level of irradiated cells was higher than in controls (1512 +/- 157.5 vs. 973.7 +/- 54.2 rho g PGE(2)/mL; p < 0.005, n = 4) while cells irradiated in the presence of NS-398 had reduced PGE(2) levels (218.8 +/- 80.1 rho g PGE(2)/mL; p < 0.005; n = 4), We found no differences in cell cycle distribution or apoptosis between cells irradiated in the presence or absence of NS-398, Conclusions: COX-2 protein is upregulated and enzymatically active after irradiation, resulting in elevated levels of PGE(2). This effect can be suppressed by NS-398, which has clinical implications for therapies combining COX-2 inhibitors with radiation therapy. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:325 / 328
页数:4
相关论文
共 50 条
  • [21] Transcriptional regulation of cyclooxygenase-2 (COX-2) in hypoxia
    Cook-Johnson, Rebecca J.
    Peet, Dan
    Gamble, Jenny
    Cleland, Leslie
    James, Michael
    INFLAMMATION RESEARCH, 2005, 54 : S183 - S183
  • [22] Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma
    Onguru, Onder
    Gamsizkan, Mehmet
    Ulutin, Cuneyt
    Gunhan, Omer
    NEUROPATHOLOGY, 2008, 28 (01) : 29 - 34
  • [23] Effect of glycosylation of cyclooxygenase-2 (COX-2) on homodimerization
    Vann-Victorino, Daniel DeWayne Colbert
    Cunanan, Jelaine
    Chen, Mindy
    Chan, Rena
    Hall, Randall W.
    Sevigny, Mary B.
    FASEB JOURNAL, 2017, 31
  • [24] APRICOXIB Cyclooxygenase-2 (COX-2) Inhibitor Oncolytic
    Edelman, Martin J.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 503 - 509
  • [25] Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
    Sokolowski, Grzegorz
    Baldys-Waligorska, Agata
    Trofimiuk, Malgorzata
    Adamek, Dariusz
    Hubalewska-Dydejczyk, Alicja
    Golkowski, Filip
    MEDICAL SCIENCE MONITOR, 2012, 18 (04): : CR252 - CR259
  • [26] Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma
    Onguru, Onder
    Gamsizkan, Mehmet
    Ulutin, Cuneyt
    Gunhan, Omer
    VIRCHOWS ARCHIV, 2007, 451 (02) : 238 - 238
  • [27] Cyclooxygenase-2 (COX-2) Activity is Regulated by Proteolysis
    Mancini, Arturo
    He, QingWen
    Di Battista, John A.
    INFLAMMATION RESEARCH, 2005, 54 : S120 - S120
  • [28] Glycosylation of cyclooxygenase-2 (COX-2) influences the migratory and invasive potential of cells
    Algaly, F. S.
    Hand, J.
    Sevigny, M. B.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [29] Expression of cyclooxygenase-2 (COX-2) in human leukemias and hematopoietic cells.
    Lilly, MB
    Drapiza, L
    Sheth, M
    Zemskova, M
    Bashkirova, S
    Morris, J
    BLOOD, 2004, 104 (11) : 168B - 168B
  • [30] Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
    Yoshida, Seiya
    Ujiki, Michael
    Ding, Xian-Zhong
    Pelham, Carolyn
    Talamonti, Mark S.
    Bell, Richard H., Jr.
    Denham, Woody
    Adrian, Thomas E.
    MOLECULAR CANCER, 2005, 4 (1)